Similar articles

• [Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].

  Lowenstein W, Haas C, Durand H. Lowenstein W, et al. Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:75-8. Ann Med Interne (Paris). 1994. PMID: 7880032 Review. French. No abstract available.
• Intravenous heroin use: its association with HIV infection in patients in methadone treatment.

  Chu A, Brown LS, Banks S, Nemoto T, Primm BJ. Chu A, et al. NIDA Res Monogr. 1989;95:447-8. NIDA Res Monogr. 1989. PMID: 2641025 No abstract available.
• [Administrative, social and clinical facilities of the implementation of the methadone program in Bordeaux].

  Tignol J. Tignol J. Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:43-5. Ann Med Interne (Paris). 1994. PMID: 7880016 French. No abstract available.
• Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment.

  Darke S, Baker A, Dixon J, Wodak A, Heather N. Darke S, et al. Drug Alcohol Depend. 1992 Feb;29(3):263-8. doi: 10.1016/0376-8716(92)90101-h. Drug Alcohol Depend. 1992. PMID: 1559433
• [Treatment of drug-dependent patients with methadone. 2: AIDS prevention by drug substitution?].

  Böcker FM. Böcker FM. Fortschr Med. 1991 Feb 20;109(5):132-5. Fortschr Med. 1991. PMID: 2045035 Review. German.